Annual Working Capital:
$502.93M+$359.67M(+251.05%)Summary
- As of today, CPRX annual working capital is $502.93 million, with the most recent change of +$359.67 million (+251.05%) on December 31, 2024.
 - During the last 3 years, CPRX annual working capital has risen by +$319.89 million (+174.76%).
 - CPRX annual working capital is now at all-time high.
 
Performance
CPRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Working Capital:
$645.73M+$71.66M(+12.48%)Summary
- As of today, CPRX quarterly working capital is $645.73 million, with the most recent change of +$71.66 million (+12.48%) on June 30, 2025.
 - Over the past year, CPRX quarterly working capital has increased by +$263.62 million (+68.99%).
 - CPRX quarterly working capital is now at all-time high.
 
Performance
CPRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CPRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | 
|---|---|---|
| 1Y1 Year | +251.1% | +69.0% | 
| 3Y3 Years | +174.8% | +193.4% | 
| 5Y5 Years | +476.3% | +482.0% | 
CPRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +251.1% | at high | +381.1% | 
| 5Y | 5-Year | at high | +476.3% | at high | +416.1% | 
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% | 
CPRX Working Capital History
| Date | Annual | Quarterly | 
|---|---|---|
| Jun 2025 | -  | $645.73M(+12.5%)  | 
| Mar 2025 | -  | $574.07M(+14.1%)  | 
| Dec 2024 | $502.93M(+251.0%)  | $502.93M(+16.0%)  | 
| Sep 2024 | -  | $433.60M(+13.5%)  | 
| Jun 2024 | -  | $382.11M(+17.6%)  | 
| Mar 2024 | -  | $325.04M(+126.9%)  | 
| Dec 2023 | $143.27M(-45.6%)  | $143.27M(+6.7%)  | 
| Sep 2023 | -  | $134.21M(-28.8%)  | 
| Jun 2023 | -  | $188.47M(+32.5%)  | 
| Mar 2023 | -  | $142.20M(-46.0%)  | 
| Dec 2022 | $263.21M(+43.8%)  | $263.21M(+13.6%)  | 
| Sep 2022 | -  | $231.63M(+5.3%)  | 
| Jun 2022 | -  | $220.07M(+11.0%)  | 
| Mar 2022 | -  | $198.25M(+8.3%)  | 
| Dec 2021 | $183.04M(+34.1%)  | $183.04M(+6.3%)  | 
| Sep 2021 | -  | $172.18M(+7.5%)  | 
| Jun 2021 | -  | $160.17M(+8.9%)  | 
| Mar 2021 | -  | $147.10M(+7.8%)  | 
| Dec 2020 | $136.49M(+56.4%)  | $136.49M(+9.1%)  | 
| Sep 2020 | -  | $125.11M(+12.8%)  | 
| Jun 2020 | -  | $110.95M(+11.7%)  | 
| Mar 2020 | -  | $99.31M(+13.8%)  | 
| Dec 2019 | $87.26M(+91.1%)  | $87.26M(+20.2%)  | 
| Sep 2019 | -  | $72.60M(+25.4%)  | 
| Jun 2019 | -  | $57.90M(+26.3%)  | 
| Mar 2019 | -  | $45.84M(+0.4%)  | 
| Dec 2018 | $45.68M(-43.6%)  | $45.68M(-22.6%)  | 
| Sep 2018 | -  | $59.01M(-10.6%)  | 
| Jun 2018 | -  | $66.00M(-13.4%)  | 
| Mar 2018 | -  | $76.20M(-5.8%)  | 
| Dec 2017 | $80.92M(+105.6%)  | $80.92M(+155.4%)  | 
| Sep 2017 | -  | $31.68M(-6.6%)  | 
| Jun 2017 | -  | $33.91M(-4.6%)  | 
| Mar 2017 | -  | $35.55M(-9.7%)  | 
| Dec 2016 | $39.36M(-30.3%)  | $39.36M(-8.6%)  | 
| Sep 2016 | -  | $43.06M(-7.1%)  | 
| Jun 2016 | -  | $46.37M(-8.8%)  | 
| Mar 2016 | -  | $50.81M(-10.0%)  | 
| Dec 2015 | $56.46M  | $56.46M(-8.9%)  | 
| Date | Annual | Quarterly | 
|---|---|---|
| Sep 2015 | -  | $61.97M(-5.7%)  | 
| Jun 2015 | -  | $65.71M(-6.3%)  | 
| Mar 2015 | -  | $70.12M(+84.7%)  | 
| Dec 2014 | $37.97M(+63.8%)  | $37.97M(-4.7%)  | 
| Sep 2014 | -  | $39.83M(-8.4%)  | 
| Jun 2014 | -  | $43.49M(+120.4%)  | 
| Mar 2014 | -  | $19.73M(-14.9%)  | 
| Dec 2013 | $23.18M(+53.7%)  | $23.18M(-9.6%)  | 
| Sep 2013 | -  | $25.63M(+136.3%)  | 
| Jun 2013 | -  | $10.85M(-19.2%)  | 
| Mar 2013 | -  | $13.42M(-11.0%)  | 
| Dec 2012 | $15.08M(+179.5%)  | $15.08M(+33.1%)  | 
| Sep 2012 | -  | $11.33M(+61.8%)  | 
| Jun 2012 | -  | $7.00M(+71.4%)  | 
| Mar 2012 | -  | $4.09M(-24.3%)  | 
| Dec 2011 | $5.39M(-1.5%)  | $5.39M(+40.2%)  | 
| Sep 2011 | -  | $3.85M(-21.8%)  | 
| Jun 2011 | -  | $4.92M(-21.2%)  | 
| Mar 2011 | -  | $6.24M(+13.9%)  | 
| Dec 2010 | $5.48M(-27.9%)  | $5.48M(-8.1%)  | 
| Sep 2010 | -  | $5.96M(+10.5%)  | 
| Jun 2010 | -  | $5.39M(-18.6%)  | 
| Mar 2010 | -  | $6.63M(-12.7%)  | 
| Dec 2009 | $7.59M(-27.6%)  | $7.59M(+60.6%)  | 
| Sep 2009 | -  | $4.73M(-20.1%)  | 
| Jun 2009 | -  | $5.92M(-22.2%)  | 
| Mar 2009 | -  | $7.61M(-27.4%)  | 
| Dec 2008 | $10.49M(-35.4%)  | $10.49M(-25.1%)  | 
| Sep 2008 | -  | $14.00M(+10.6%)  | 
| Jun 2008 | -  | $12.66M(-15.1%)  | 
| Mar 2008 | -  | $14.90M(-8.2%)  | 
| Dec 2007 | $16.23M(-18.1%)  | $16.23M(-4.8%)  | 
| Sep 2007 | -  | $17.04M(-4.0%)  | 
| Jun 2007 | -  | $17.76M(-5.6%)  | 
| Mar 2007 | -  | $18.81M(-5.1%)  | 
| Dec 2006 | $19.82M(+4523.2%)  | $19.82M(+754.0%)  | 
| Sep 2006 | -  | $2.32M(+2256.3%)  | 
| Jun 2006 | -  | -$107.60K(-125.1%)  | 
| Dec 2005 | $428.60K(+269.2%)  | $428.60K(+269.2%)  | 
| Dec 2004 | $116.10K  | $116.10K  | 
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual working capital?
 - What is the all-time high annual working capital for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. annual working capital year-on-year change?
 - What is Catalyst Pharmaceuticals, Inc. quarterly working capital?
 - What is the all-time high quarterly working capital for Catalyst Pharmaceuticals, Inc.?
 - What is Catalyst Pharmaceuticals, Inc. quarterly working capital year-on-year change?
 
What is Catalyst Pharmaceuticals, Inc. annual working capital?
The current annual working capital of CPRX is $502.93M
What is the all-time high annual working capital for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual working capital is $502.93M
What is Catalyst Pharmaceuticals, Inc. annual working capital year-on-year change?
Over the past year, CPRX annual working capital has changed by +$359.67M (+251.05%)
What is Catalyst Pharmaceuticals, Inc. quarterly working capital?
The current quarterly working capital of CPRX is $645.73M
What is the all-time high quarterly working capital for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly working capital is $645.73M
What is Catalyst Pharmaceuticals, Inc. quarterly working capital year-on-year change?
Over the past year, CPRX quarterly working capital has changed by +$263.62M (+68.99%)